Tixupharma
Discovery platform to develop metabolic therapeutics to treat immuno-aging and trauma diseases
Tixupharma is an innovative drug and medical device company based in Milan, established in 2013 as academic spin-out and consolidated in 2019 to pioneer the regenerative medicine space by leveraging emerging strategy in traumatic and age-related diseases to activate untapped regenerative and immuno-shielding patterns. Our mission is to develop first-in-class such therapeutics to treat immunoaging and traumatic diseases by leveraging metabolic driving-forces.
Team
Nessun founder mappato su questa scheda. Aggiungili
